 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[34m                Passages:[0m
[34m                [0m[1;34m1[0m[34m. Drug WARFARIN: The final answer to the question [0m[34m"Does WARFARIN increase or decrease the risk of hospitalization?"[0m[34m is that WARFARIN does not directly increase or decrease the risk of[0m
[34mhospitalization. The risk of hospitalization may be influenced by the management of the drug and the prevention of complications such as major bleeding events and thromboembolism. Regular monitoring [0m
[34mand appropriate management are essential to minimize these risks. This information is based on the response from FDAHandler, which referenced the WARFARIN label and clinical studies showing the [0m
[34massociation between warfarin therapy and major bleeding events.[0m
[34m                ---------[0m
[34m                Does the warfarin category of drugs increase the risk of[0m
[34m                hospitalization, decrease it, or is there no clear effect?[0m
[34m            [0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.AGENT [0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"The passage states that WARFARIN does not directly increase or decrease the risk of hospitalization."[0m[32m,[0m
[32m      [0m[32m"The risk of hospitalization may be influenced by the management of the drug and the prevention of complications such as major bleeding events and thromboembolism."[0m[32m,[0m
[32m      [0m[32m"Regular monitoring and appropriate management are essential to minimize these risks."[0m[32m,[0m
[32m      [0m[32m"This information is based on the response from FDAHandler, which referenced the WARFARIN label and clinical studies showing the association between warfarin therapy and major bleeding events."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"There is no clear effect of the warfarin category of drugs on the risk of hospitalization, as it depends on the management of the drug and the prevention of complications."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"The passage states that WARFARIN does not directly increase or decrease the risk of hospitalization."[0m[34m,[0m
[34m      [0m[34m"The risk of hospitalization may be influenced by the management of the drug and the prevention of complications such as major bleeding events and thromboembolism."[0m[34m,[0m
[34m      [0m[34m"Regular monitoring and appropriate management are essential to minimize these risks."[0m[34m,[0m
[34m      [0m[34m"This information is based on the response from FDAHandler, which referenced the WARFARIN label and clinical studies showing the association between warfarin therapy and major bleeding events."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"There is no clear effect of the warfarin category of drugs on the risk of hospitalization, as it depends on the management of the drug and the prevention of complications."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. The passage states that WARFARIN does not directly increase or decrease the risk of hospitalization.[0m
[1;31m2[0m[31m. The risk of hospitalization may be influenced by the management of the drug and the prevention of complications such as major bleeding events and thromboembolism.[0m
[1;31m3[0m[31m. Regular monitoring and appropriate management are essential to minimize these risks.[0m
[1;31m4[0m[31m. This information is based on the response from FDAHandler, which referenced the WARFARIN label and clinical studies showing the association between warfarin therapy and major bleeding events.[0m
[31m        -----[0m
[31m        Final answer: There is no clear effect of the warfarin category of drugs on the risk of hospitalization, as it depends on the management of the drug and the prevention of complications.[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m"The reasoning provided is flawed because it does not directly answer the question based on the evidence from the FDA data. The user's reasoning includes a consideration of the [0m
[32mmanagement of the drug and the prevention of complications, which is beyond the scope of the question. The question asks for a direct link between the warfarin category of drugs and the risk of [0m
[32mhospitalization based on the specified passages. If the passage explicitly states that warfarin does not directly increase or decrease the risk of hospitalization, then the correct answer should be [0m
[32mthat there is no clear effect of the warfarin category of drugs on the risk of hospitalization, without adding conditions about drug management and prevention of complications. The answer should be [0m
[32mbased solely on the evidence provided in the FDA data and should not include additional considerations or assumptions."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m"The reasoning provided is flawed because it does not directly answer the question based on the evidence from the FDA data. The user's reasoning includes a consideration of the [0m
[34mmanagement of the drug and the prevention of complications, which is beyond the scope of the question. The question asks for a direct link between the warfarin category of drugs and the risk of [0m
[34mhospitalization based on the specified passages. If the passage explicitly states that warfarin does not directly increase or decrease the risk of hospitalization, then the correct answer should be [0m
[34mthat there is no clear effect of the warfarin category of drugs on the risk of hospitalization, without adding conditions about drug management and prevention of complications. The answer should be [0m
[34mbased solely on the evidence provided in the FDA data and should not include additional considerations or assumptions."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Feedback: The reasoning provided is flawed because it does not directly answer the question based on the evidence from the FDA data. The user's reasoning includes a consideration of the [0m
[31mmanagement of the drug and the prevention of complications, which is beyond the scope of the question. The question asks for a direct link between the warfarin category of drugs and the risk of [0m
[31mhospitalization based on the specified passages. If the passage explicitly states that warfarin does not directly increase or decrease the risk of hospitalization, then the correct answer should be [0m
[31mthat there is no clear effect of the warfarin category of drugs on the risk of hospitalization, without adding conditions about drug management and prevention of complications. The answer should be [0m
[31mbased solely on the evidence provided in the FDA data and should not include additional considerations or assumptions.[0m

[31m        If any flaws in the reasoning used to produce your[0m
[31m        answer were identified, you must try again.[0m
[31m        [0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.USER [0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"The passage explicitly states that WARFARIN does not directly increase or decrease the risk of hospitalization."[0m[32m,[0m
[32m      [0m[32m"The risk factors mentioned, such as the management of the drug and the prevention of complications, are not direct effects of the drug itself but are related to its use and management."[0m[32m,[0m
[32m      [0m[32m"The information provided is based on the WARFARIN label and clinical studies, which are reliable sources of evidence."[0m[32m,[0m
[32m      [0m[32m"Therefore, based on the passage provided, the warfarin category of drugs does not have a clear direct effect on the risk of hospitalization."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"There is no clear direct effect of the warfarin category of drugs on the risk of hospitalization, according to the passage provided."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"The passage explicitly states that WARFARIN does not directly increase or decrease the risk of hospitalization."[0m[34m,[0m
[34m      [0m[34m"The risk factors mentioned, such as the management of the drug and the prevention of complications, are not direct effects of the drug itself but are related to its use and management."[0m[34m,[0m
[34m      [0m[34m"The information provided is based on the WARFARIN label and clinical studies, which are reliable sources of evidence."[0m[34m,[0m
[34m      [0m[34m"Therefore, based on the passage provided, the warfarin category of drugs does not have a clear direct effect on the risk of hospitalization."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"There is no clear direct effect of the warfarin category of drugs on the risk of hospitalization, according to the passage provided."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does the warfarin category of drugs increase the risk of hospitalization, decrease it, or is there no clear effect?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. The passage explicitly states that WARFARIN does not directly increase or decrease the risk of hospitalization.[0m
[1;31m2[0m[31m. The risk factors mentioned, such as the management of the drug and the prevention of complications, are not direct effects of the drug itself but are related to its use and management.[0m
[1;31m3[0m[31m. The information provided is based on the WARFARIN label and clinical studies, which are reliable sources of evidence.[0m
[1;31m4[0m[31m. Therefore, based on the passage provided, the warfarin category of drugs does not have a clear direct effect on the risk of hospitalization.[0m
[31m        -----[0m
[31m        Final answer: There is no clear direct effect of the warfarin category of drugs on the risk of hospitalization, according to the passage provided.[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m"The revised reasoning is correct. It focuses on the direct effects of the warfarin category of drugs on the risk of hospitalization as stated in the passage. The reasoning now [0m
[32mproperly excludes considerations about drug management and prevention of complications, which are not direct effects of the drug itself. The conclusion that there is no clear direct effect on the risk[0m
[32mof hospitalization is consistent with the evidence provided in the FDA data."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m"The revised reasoning is correct. It focuses on the direct effects of the warfarin category of drugs on the risk of hospitalization as stated in the passage. The reasoning now [0m
[34mproperly excludes considerations about drug management and prevention of complications, which are not direct effects of the drug itself. The conclusion that there is no clear direct effect on the risk[0m
[34mof hospitalization is consistent with the evidence provided in the FDA data."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Feedback: The revised reasoning is correct. It focuses on the direct effects of the warfarin category of drugs on the risk of hospitalization as stated in the passage. The reasoning now [0m
[31mproperly excludes considerations about drug management and prevention of complications, which are not direct effects of the drug itself. The conclusion that there is no clear direct effect on the risk[0m
[31mof hospitalization is consistent with the evidence provided in the FDA data.[0m

[31m        If any flaws in the reasoning used to produce your[0m
[31m        answer were identified, you must try again.[0m
[31m        [0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.USER [0m
 [1m([0moverall-effect-hospitalization-warfarin[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mcategory_effect_tool[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"category_effect_tool"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"label"[0m[32m: [0m[32m"no-effect"[0m[32m,[0m
[32m    [0m[32m"confidence"[0m[32m: [0m[1;32m0.9[0m[32m,[0m
[32m    [0m[32m"probability"[0m[32m: [0m[1;32m0.0[0m[32m,[0m
[32m    [0m[32m"frequency"[0m[32m: [0m[32m"none"[0m[32m,[0m
[32m    [0m[32m"evidence"[0m[32m: [0m[32m"strong"[0m[32m,[0m
[32m    [0m[32m"justification"[0m[32m: [0m[32m"The passage explicitly states that WARFARIN does not directly increase or decrease the risk of hospitalization. The information is based on the WARFARIN label and clinical [0m
[32mstudies, which are considered reliable sources. Therefore, there is strong evidence to support that there is no direct effect of the warfarin category of drugs on the risk of hospitalization."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-hospitalization-warfarin[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mcategory_effect_tool[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m
